The Competition Commission of India (CCI) has pointed at "unreasonably high trade margins" as responsible for exorbitant drug prices, highlighting the role of intermediaries in increasing prices of medicines along with need to promote generic medicines with quality assurance.
from Times of India https://ift.tt/2Rddurk
via IFTTT
No comments:
Post a Comment